Fetal Growth and Placental Function in Pregnancies Complicated by Diabetes
NCT04801121 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-07-26
Summary
Diabetic pregnancies are often complicated by placental dysfunction with reduced transfer of oxygen from the mother to the fetus, which may compromise fetal growth and organ development. In diabetic pregnancies, hyperinsulinemia and hyperglycemia very often leads to fetal macrosomia. The combination of reduced placental oxygen transfer and increasing fetal demand due to fetal overgrowth may possess a particular risk of adverse pregnancy outcome.
Current methods in the antenatal identification of placental dysfunction relies on estimates of fetal size and fetal wellbeing using ultrasound including Doppler flows measurements. These measurements are only indirect estimates of placental function, as no clinical method exists to assess placental function directly. In diabetic pregnancies, the estimates are further limited due to fetal overgrowth and unreliable Doppler. In addition, in diabetic pregnancies, intrauterine fetal weight estimates by ultrasound are inaccurate because of asymmetric fetal growth. Therefore, new accurate methods to assess placental function, fetal oxygenation and fetal growth in this particular group of high-risk pregnancies is highly needed. Early and precise identification of pathology in diabetes pregnancy may lead to an improved outcome in the offspring, as precise identification of pathology facilitates important obstetric decisions in regards to maternal antidiabetic treatment and timing of delivery. Resent research indicates that MRI is useful for this purpose.
It is well described, that preeclampsia is associated with an increased maternal risk of cardiovascular disease later in life. Recent studies suggest, that pregestational subclinical cardiovascular dysfunction, in particular left ventricular dysfunction, may increase the risk of preeclampsia and fetal growth restriction during pregnancy. Cardiac MRI is a sensitive method to detect subclinical maternal cardiac dysfunction, which may be used in identification of high-risk pregnancies. In addition, the longitudinal design of this study allows for the investigation of cardiovascular changes during pregnancies in normal pregnancies and pregnancies complicated by diabetes.
The overall aim of this study is to improve the antenatal fetal and maternal monitoring in diabetes pregnancies. Early and precise identification of pregnancy pathology provides a better basis for important obstetric decisions regarding antidiabetic treatment, monitoring intervals and timing of delivery, which leads to a better outcome for the mother and offspring.
Hypothesis
Project A:
Placental function and fetal oxygenation in diabetic pregnancies estimated by T2\* weighted placental and fetal MRI
Aim: To investigate placental function and fetal oxygenation by longitudinal T2\* weighted placental MRI and the association with pregnancy complications.
Hypothesis:
* Diabetic pregnancies are characterized by placental hypoxia (low T2\* value)
* Diabetic pregnancies are characterized by fetal hypoxia (low T2\* value)
* Fetal and placental hypoxia is a risk factor of placental related complications in pregnancy such as low birth weight, preterm delivery, acute cesarean sections and preeclampsia.
Project B: Fetal growth and the growth of selected fetal organs in diabetic pregnancies estimated by longitudinal MRI volumetry
Aim: To investigate growth velocity of the fetus and selected fetal organs and the correlation with pregnancy complications.
Hypothesis:
* Diabetic pregnancies are characterized by accelerated fetal growth in the third trimester
* Diabetic pregnancies are characterized by asymmetric growth (reduced brain/liver-volume ratio)
* Abnormal fetal growth is associated with dysregulated maternal diabetes.
* Abnormal fetal growth is a risk factor of pregnancy complications such as; macrosomia, preterm delivery and acute cesarean sections.
Project C:
Maternal cardiac function in diabetic pregnancies estimated by MRI
Aim: To investigate maternal cardiac function and the correlation with pregnancy complications such as preeclampsia and fetal growth restriction.
Hypothesis:
* Maternal cardiac function is altered in diabetes pregnancies when compared to normal pregnancies.
* Impaired cardiac function (left ventricular dysfunction) is a risk factor of preeclampsia and fetal growth restriction.
Conditions
- Pregnancy in Diabetics
- Placenta
- Fetal Growth
- Magnetic Resonance Imaging
Sponsors & Collaborators
-
Aarhus University Hospital
collaborator OTHER -
University of Nottingham
collaborator OTHER -
Sidsel Linneberg Rathcke
lead OTHER
Principal Investigators
-
Sidsel L Rathcke, MD · Aalborg University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-11-01
- Primary Completion
- 2023-06-30
- Completion
- 2023-10-31
Countries
- Denmark
Study Locations
More Related Trials
-
A Prospective Study Comparing the Incidence of Infantile Hemangiomas Following Normal Pregnancies Versus Pregnancies Complicated by Placental Abnormalities
NCT00490607 ·Status: UNKNOWN
-
Exploration of the Lipid Metabolism During the Diabetic Pregnancies
NCT00639964 ·Status: COMPLETED ·Phase: NA
-
Fetal Distribution of Feto-placental Blood Flow Related to Placental Nutrient Transport and Maternal Food Intake
NCT04215107 ·Status: UNKNOWN ·Phase: NA
-
Cologne Placenta Cohort (CPC)
NCT05424965 ·Status: UNKNOWN
-
Fetal Heart Rate Variability and Fetal Growth Restriction
NCT04288037 ·Status: UNKNOWN
-
Is Serum YKL-40 Capable of Predicting Intrauterine Growth Restriction (IUGR) and Preeclampsia?
NCT00836524 ·Status: UNKNOWN
-
Innovations in Placental Metabolism and Association With Antioxidants and Nutrients in Diabetes and Gestational Obesity
NCT05174728 ·Status: SUSPENDED
-
Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
NCT05023161 ·Status: RECRUITING
-
Possible Epigenetic Changes in Offspring of Women With Pregestational and Gestational Diabetes
NCT01255384 ·Status: UNKNOWN
-
Maternal and Fetal Metabolic Changes
NCT06288126 ·Status: COMPLETED
-
Regulation Of Maternal Fuel Supply And Neonatal Adiposity
NCT00826904 ·Status: COMPLETED
-
Maternal Adipose Tissue and Placental Dysfunction Programs the Fetus for Type 2 Diabetes (PlacentA-DM)
NCT02211651 ·Status: COMPLETED
-
Water Immersion and Changes in the Fetoplacental Circulation
NCT01799343 ·Status: COMPLETED ·Phase: NA
-
Placental Characteristics Within Monochorionic Twin Pregnancies
NCT07124312 ·Status: RECRUITING
-
Placental Growth Factor as a Predictor of Adverse Pregnancy Outcomes in Preeclamptic Women
NCT04374604 ·Status: COMPLETED
-
Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus
NCT01821053 ·Status: COMPLETED
-
Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
NCT05952583 ·Status: RECRUITING
-
Pregnancies Complicated by Fetal Anomalies
NCT02505464 ·Status: RECRUITING
-
Predicting Placental Pathologies by Ultrasound Imaging
NCT04506970 ·Status: COMPLETED
-
Placental Volume, Flow, and Vascularity Study
NCT04900207 ·Status: COMPLETED
-
Study of Placental Vascularization Using Contrast Ultrasound
NCT06497959 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Placental Function in Healthy and Pathological Pregnancies
NCT02321007 ·Status: RECRUITING
-
The Use of the CPR to Predict Adverse Outcomes in GDM Pregnancies
NCT03072563 ·Status: UNKNOWN
-
Birth Weight-discordance in Twins Pregnancy: a Multicenter Retrospective Study
NCT05674214 ·Status: COMPLETED
-
Mild Fetal Hydronephrosis, Gestational Diabetes and Spontaneous Resolution vs Moderate-severe Fetal Hydronephrosis, Obstructive Causes and Worse Postnatal Outcome
NCT06896149 ·Status: NOT_YET_RECRUITING